You have been doing everything right — eating well, tracking your cycle, taking your prenatal vitamin every single day — and yet something still feels off. What if the problem is not how much folate you are getting, but which form? For women with an MTHFR gene variant, this distinction is not a minor detail. It is the difference between a supplement that works and one that quietly fails you at the cellular level.
The MTHFR gene encodes an enzyme responsible for converting folic acid into its active, usable form: 5-methyltetrahydrofolate, or methylfolate. When this gene is mutated — as it is in an estimated 10 to 15 percent of women with the most significant variant — that conversion is impaired by up to 70 percent. The result is insufficient methylfolate circulating in the body despite adequate folic acid intake, which can compromise DNA synthesis, homocysteine metabolism, and embryo development during the earliest and most critical weeks of pregnancy.
In the sections ahead, we will break down exactly how folic acid and methylfolate differ, why the MTHFR mutation changes everything about your supplement strategy, what the current research says about each form and conception outcomes, and how to choose a prenatal that genuinely meets your needs. Whether you have already tested positive for MTHFR or you are simply trying to optimise your preconception nutrition, this guide is for you.
What Is MTHFR and Why Does It Change Your Folate Needs?
MTHFR stands for methylenetetrahydrofolate reductase, a key enzyme in the folate metabolic pathway. Its job is to catalyse the conversion of 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate — the bioactive form of folate that the body can actually use. This active form is essential for the remethylation of homocysteine to methionine, a process that underpins DNA methylation, cellular repair, and neurotransmitter synthesis.
The two most studied MTHFR mutations are C677T and A1298C. Women who are homozygous for C677T (meaning they carry two copies of the variant) experience the greatest reduction in enzyme activity, sometimes as much as 70 percent. Heterozygous carriers still show impaired function, typically between 30 and 40 percent reduced capacity. This means even a mild variant can meaningfully affect how your body processes synthetic folic acid.
From a fertility standpoint, impaired MTHFR function is associated with elevated homocysteine levels, which can damage the uterine lining, impair implantation, and increase the risk of early pregnancy loss. Folate is also essential for neural tube formation, which occurs in the first 28 days after conception — often before a woman even knows she is pregnant. This is why preconception supplementation matters so deeply, and why the form you choose is not trivial.
- Get tested for MTHFR variants through your GP or a functional medicine practitioner before or during preconception planning
- Ask for a homocysteine blood test to assess your methylation status and cardiovascular risk baseline
- Review your current prenatal label — look for “methylfolate” or “5-MTHF” rather than just “folic acid”
- Discuss your results with a healthcare provider who understands nutrigenomics and fertility nutrition
- Consider genetic testing services that include MTHFR alongside other reproductive health markers
You can read more about how folate vs folic acid affects conception in our dedicated guide, which covers the foundational chemistry behind each form in accessible detail.
Folic Acid vs Methylfolate: What the Research Actually Shows
Folic acid is the synthetic, oxidised form of vitamin B9. It is the version most commonly found in fortified foods and standard prenatal vitamins, and it has been recommended since the 1990s as a primary strategy for neural tube defect prevention. There is no question that folic acid supplementation has dramatically reduced rates of spina bifida and anencephaly in the general population. However, folic acid must undergo several enzymatic steps before the body can use it — and MTHFR variants significantly slow that conversion process.
Methylfolate (also labelled as 5-MTHF, Quatrefolic, or Metafolin) is the already-active form. It bypasses the enzymatic conversion process entirely, making it immediately bioavailable regardless of MTHFR status. A 2011 study published in Nutrients found that methylfolate was more effective at raising plasma folate levels in women with MTHFR C677T polymorphisms compared to an equivalent dose of folic acid. This is not a small distinction — it has real implications for red blood cell folate stores, which directly influence embryo quality and early fetal development.
An additional concern with high-dose folic acid in MTHFR carriers is unmetabolised folic acid (UMFA) accumulating in the bloodstream. Some researchers have raised concerns that UMFA may mask B12 deficiency and potentially interfere with natural killer cell activity, though this research is still evolving. What is clear is that for women who cannot efficiently process folic acid, supplementing with methylfolate is both a safer and more effective strategy.
- Choose prenatal vitamins that list “methylfolate,” “5-MTHF,” “Quatrefolic,” or “Metafolin” on the label
- Aim for 400–800 mcg of methylfolate daily during preconception; your provider may recommend higher doses for MTHFR homozygotes
- Pair methylfolate with methylcobalamin (active B12), as both nutrients work together in the methylation cycle
- Avoid prenatal vitamins that contain only cyanocobalamin and folic acid if you have a confirmed MTHFR variant
- Store methylfolate supplements away from heat and light to preserve potency
The Thorne Basic Prenatal with Folate and Choline is a widely trusted option that uses active folate rather than synthetic folic acid, making it particularly suitable for women with MTHFR concerns. Similarly, the Ritual Essential for Women Prenatal Multivitamin uses methylated folate and is formulated with transparency around its ingredient sourcing.
How MTHFR Affects Implantation, Miscarriage Risk, and Early Pregnancy
The connection between MTHFR mutations, inadequate methylfolate, and pregnancy complications is one of the most important — and most underappreciated — areas of reproductive medicine. Folate plays a central role in DNA replication and repair, and rapidly dividing cells like those of a newly formed embryo are especially vulnerable to folate insufficiency. When methylation pathways are impaired, chromosomal abnormalities, poor embryo quality, and failed implantation become more likely.
Elevated homocysteine, a hallmark of impaired MTHFR function, is particularly damaging to the endometrium. Research published in the American Journal of Reproductive Immunology has linked hyperhomocysteinaemia with defective trophoblast invasion — the process by which the embryo embeds itself into the uterine lining. Women with recurrent implantation failure undergoing IVF have been found to have significantly higher rates of MTHFR variants compared to the general population, according to multiple meta-analyses.
Recurrent pregnancy loss is another area where MTHFR status deserves careful attention. A 2015 meta-analysis in PLOS ONE found that women carrying the C677T homozygous mutation had a significantly elevated risk of recurrent miscarriage. While not every miscarriage in MTHFR carriers is directly caused by the mutation, correcting the underlying methylation deficiency through appropriate supplementation is a rational and evidence-supported step.
Beyond the embryo itself, adequate methylfolate supports maternal wellbeing during early pregnancy. It contributes to serotonin and dopamine synthesis, which may help explain why some women with MTHFR variants experience worsened mood symptoms during pregnancy — a finding that underscores the whole-body importance of methylation support. Our article on supplements that help with implantation explores additional nutrients that work synergistically with folate to support the uterine environment.
Choosing the Right Prenatal Vitamin When You Have MTHFR
Selecting a prenatal vitamin when you carry an MTHFR variant requires more than reading the front label. Many products market themselves with “folate” prominently displayed while burying folic acid in the ingredient list — and the two are not interchangeable for your purposes. Here is what to look for, and what to avoid, when evaluating your options.
First, confirm the exact form of folate used. Acceptable forms for MTHFR carriers include 5-methyltetrahydrofolate, L-methylfolate, Quatrefolic (a branded form of 5-MTHF), and Metafolin. Any product listing only “folic acid” as its folate source is not appropriate as a standalone supplement for women with confirmed MTHFR mutations.
Second, check the B12 form. Cyanocobalamin is the synthetic form that also requires enzymatic conversion — the same pathway impaired by MTHFR. Methylcobalamin or adenosylcobalamin are the active, bioavailable forms that do not rely on that conversion. Women with MTHFR variants ideally want both their folate and their B12 in already-activated forms. You can learn more about how B12 deficiency affects fertility and why the two nutrients are deeply interconnected.
Third, consider whether your prenatal includes choline, which supports the one-carbon metabolic cycle and complements folate in neural tube protection. Doses of 400–550 mg per day are generally recommended during pregnancy. The MegaFood Baby and Me 2 Prenatal Multivitamin and the New Chapter Prenatal Vitamins Organic Non GMO are both food-based formulas that offer a more complete micronutrient profile for preconception support. If you are looking for a comprehensive overview, our guide to the best prenatal vitamins includes options specifically evaluated for MTHFR-friendly formulation.
Frequently Asked Questions
Can I take methylfolate even if I have not been tested for MTHFR?
Yes. Methylfolate is safe for women regardless of MTHFR status. Since it is the bioavailable form that all bodies ultimately use, supplementing with it carries no risk for those without mutations and provides superior support for those who carry them.
How much methylfolate should I take when trying to conceive?
Most guidelines recommend 400–800 mcg daily for preconception. Women confirmed as homozygous for C677T may need 1,000–5,000 mcg under medical supervision. Always consult your healthcare provider before exceeding standard doses, as higher amounts warrant clinical oversight.
Does MTHFR always cause fertility problems?
Not always. Many women with MTHFR variants conceive without difficulty. However, the mutation increases certain risks — particularly for recurrent miscarriage and implantation failure — especially when combined with nutritional deficiencies or elevated homocysteine. Addressing methylation support proactively is prudent for all carriers.
Can I get enough methylfolate from food alone?
Leafy greens, legumes, liver, and eggs contain naturally occurring food folate. However, cooking reduces folate content significantly, and absorption varies. Most preconception guidelines recommend supplementation alongside a folate-rich diet rather than relying on food sources alone, especially for MTHFR carriers.
Is methylfolate safe throughout the entire pregnancy?
Yes. Methylfolate is considered safe for use throughout pregnancy and postpartum. Folate requirements increase during pregnancy to support placental development and fetal growth. Continuing methylfolate supplementation through your prenatal vitamin is appropriate and recommended across all three trimesters.
A Word From Vitamins For Woman
Navigating methylfolate vs folic acid for MTHFR and conception can feel overwhelming, but the core message is clear: the form of folate you take genuinely matters, and for women with MTHFR variants, methylfolate is the biologically appropriate choice. Getting tested, reviewing your prenatal formula, and working with a knowledgeable provider are the most impactful steps you can take right now. Your preconception window is precious — make every supplement count, and trust that small, informed changes can create meaningful differences for both your fertility and the health of your future baby.
References
- Devlin A.M. et al. (2010). Hypermethylation of Fmr1 and Pitx2 in MTHFR-deficient mice. Nutrients. https://pubmed.ncbi.nlm.nih.gov/20811557/
- Lamers Y. et al. (2006). Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women. American Journal of Clinical Nutrition. https://pubmed.ncbi.nlm.nih.gov/16469994/
- Rai V. (2016). Methylenetetrahydrofolate reductase C677T polymorphism and recurrent pregnancy loss risk: A meta-analysis. Indian Journal of Clinical Biochemistry. https://pubmed.ncbi.nlm.nih.gov/27069310/
- Pietrzik K. et al. (2010). Folic acid and L-5-methyltetrahydrofolate: Comparison of clinical pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics. https://pubmed.ncbi.nlm.nih.gov/20608756/
- Haggarty P. et al. (2013). Effect of B vitamins and genetics on success of in-vitro fertilisation: Prospective cohort study. Lancet. https://pubmed.ncbi.nlm.nih.gov/23791279/
